{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:02:24Z","timestamp":1791590544752,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jid.2016.12.007","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T02:02:15Z","timestamp":1482285735000},"page":"1033-1041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["A Functional Genomic Meta-Analysis of Clinical Trials in Systemic Sclerosis: Toward\u00a0Precision Medicine and Combination Therapy"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4734-4508","authenticated-orcid":false,"given":"Jaclyn N.","family":"Taroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Martyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Matthew","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0862-6003","authenticated-orcid":false,"given":"Michael L.","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.12.007_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.gene.6364173","article-title":"Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data","volume":"6","author":"Abbas","year":"2005","journal-title":"Genes Immun"},{"key":"10.1016\/j.jid.2016.12.007_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-015-0669-3","article-title":"Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis","volume":"17","author":"Chakravarty","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2016.12.007_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/art.24221","article-title":"Molecular framework for response to imatinib mesylate in systemic sclerosis","volume":"60","author":"Chung","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2016.12.007_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/art.27220","article-title":"A\u00a0four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"62","author":"Farina","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2016.12.007_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13075-015-0721-3","article-title":"Nilotinib (Tasigna\u2122) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial","volume":"17","author":"Gordon","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2016.12.007_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.immuni.2015.08.014","article-title":"Interactive big data resource to elucidate human immune pathways and diseases","volume":"43","author":"Gorenshteyn","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2016.12.007_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3259","article-title":"Understanding multicellular function and disease with human tissue-specific networks","volume":"47","author":"Greene","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2016.12.007_bib8","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/jid.2013.130","article-title":"Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis","volume":"133","author":"Hinchcliff","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.12.007_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1101\/gr.082214.108","article-title":"Exploring the human genome with functional maps","volume":"19","author":"Huttenhower","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.jid.2016.12.007_bib10","doi-asserted-by":"crossref","first-page":"e0114017","DOI":"10.1371\/journal.pone.0114017","article-title":"Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts","volume":"10","author":"Johnson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2016.12.007_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/annrheumdis-2015-eular.2281","article-title":"OP0054 safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis: week 48 data from the fascinate trial","volume":"74","author":"Khanna","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2016.12.007_bib12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/ard.2005.050187","article-title":"Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study","volume":"65","author":"Khanna","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2016.12.007_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.24249","article-title":"B\u00a0cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis","volume":"60","author":"Lafyatis","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2016.12.007_bib14","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jid.2016.12.007_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.jid.2016.12.007_bib16","doi-asserted-by":"crossref","first-page":"e1004005","DOI":"10.1371\/journal.pcbi.1004005","article-title":"Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms","volume":"11","author":"Mahoney","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.jid.2016.12.007_bib17","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2016.12.007_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/jid.2011.472","article-title":"Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies","volume":"132","author":"Pendergrass","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.12.007_bib19","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","article-title":"Human protein reference database\u20142009 update","volume":"37","author":"Prasad","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2016.12.007_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jid.2016.12.007_bib21","doi-asserted-by":"crossref","first-page":"W307","DOI":"10.1093\/nar\/gkr378","article-title":"g:Profiler\u2014a web server for functional interpretation of gene lists (2011 update)","volume":"39","author":"Reimand","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2016.12.007_bib22","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.12.007_bib23","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/art.39287","article-title":"A\u00a0longitudinal biomarker for the extent of skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"67","author":"Rice","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2016.12.007_bib24","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2016.12.007_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1145\/1852102.1852106","article-title":"A\u00a0similarity measure for indefinite rankings","volume":"28","author":"Webber","year":"2010","journal-title":"ACM Trans Inform Syst"},{"key":"10.1016\/j.jid.2016.12.007_bib26","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","article-title":"DSigDB: drug signatures database for gene set analysis","volume":"31","author":"Yoo","year":"2015","journal-title":"Bioinformatics"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16327944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16327944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T03:50:20Z","timestamp":1542945020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X16327944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0022202X16327944"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.12.007","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/087361","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Functional Genomic Meta-Analysis of Clinical Trials in Systemic Sclerosis: Toward\u00a0Precision Medicine and Combination Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}